Personalized ViscoElastic Testing-guided Bleeding Management In Liver Surgery, Neurosurgery and Obstetrics

NCT06635564 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 240

Last updated 2025-05-23

No results posted yet for this study

Summary

The ClotPro analyzer is a new generation viscoelastic analyzer for the in vitro assessment of blood coagulation. This study aims to assess the agreement of ClotPro 6.0, ROTEM delta, and TEG 6s in three distinct cohorts: i) patients with liver disease undergoing liver surgery, ii) pregnant women undergoing elective cesarean section, and iii) patients undergoing elective intracranial neurosurgery. Further coagulation tests will be performed (standard laboratory coagulation tests, thrombin and plasmin generation tests) in an exploratory fashion to compare them with viscoelastic test results. The obtained test results will not result in any diagnostic or therapeutic consequences for patients included in this study.

Conditions

  • Thrombelastography
  • Liver Transplant
  • Postpartum Hemorrhage
  • Bleeding Disorder
  • Intracranial Hemorrhages

Interventions

DIAGNOSTIC_TEST

Viscoelastic testing

viscoelasting testing refers to a global hemostatic assay,that quantifies the viscoelastic properties of citrated whole blood

Sponsors & Collaborators

  • Synapse - Research Institute Maastricht

    collaborator UNKNOWN
  • Medical University of Vienna

    lead OTHER

Principal Investigators

  • Johannes Gratz, PhD MD · Medical University of Vienna

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-01
Primary Completion
2026-04-30
Completion
2026-07-31

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06635564 on ClinicalTrials.gov